[Double-blind clinical study of the therapeutic use of new antacid: hydrotalcite].
D000328:Adult; D000368:Aged; D000536:Aluminum Hydroxide / Q000627:therapeutic use*; D000863:Antacids / Q000627:therapeutic use*; D002254:Carbonates / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004341:Drug Evaluation; D004361:Drug Tolerance; D004381:Duodenal Ulcer / Q000150:complications / Q000188:drug therapy; D004415:Dyspepsia / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D005756:Gastritis / Q000150:complications / Q000188:drug therapy; D006801:Humans; D008274:Magnesium / Q000627:therapeutic use*; D008276:Magnesium Hydroxide / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
D000863:Antacids; D002254:Carbonates; D000536:Aluminum Hydroxide; D008274:Magnesium; D008276:Magnesium Hydroxide
Studio clinico in doppio cieco sull'impiego terapeutico di un nuovo antiacido: l'idrotalcite.